What’s new in FY2027
Changes to the ICD-10-CM code set effective October 1, 2026, from the CMS addenda: 190 new codes, 4 revised and 30 deleted. The count of billable codes goes from 74,719 (FY2026) to 74,879 (FY2027).
POA exempt changes Revised (4) Deleted (30) New (190)
POA exempt list changes
Codes on the exempt list do not get a present on admission indicator (leave the field blank). CMS and NCHS changed the list for FY2027: 62 codes added and 12 removed, and one title was corrected. 10 of the removed codes were deleted from the code set and have no page. See Appendix I of the Official Guidelines and the POA exempt tag on each code page.
Added to the exempt list (62)
- Q87.ALoeys-Dietz syndrome
- QA1.71Lynch syndrome
- QA1.790Familial cancer syndrome with pathogenic BRCA1 mutation
- QA1.791Familial cancer syndrome with pathogenic BRCA2 mutation
- QA1.792Li Fraumeni syndrome
- QA1.798Other inherited neoplasm predisposition syndrome of multiple systems
- T52.811DToxic effect of alkenes, accidental (unintentional), subsequent encounter
- T52.811SToxic effect of alkenes, accidental (unintentional), sequela
- T52.812DToxic effect of alkenes, intentional self-harm, subsequent encounter
- T52.812SToxic effect of alkenes, intentional self-harm, sequela
- T52.813DToxic effect of alkenes, assault, subsequent encounter
- T52.813SToxic effect of alkenes, assault, sequela
- T52.814DToxic effect of alkenes, undetermined, subsequent encounter
- T52.814SToxic effect of alkenes, undetermined, sequela
- T52.821DToxic effect of cycloparaffins, accidental (unintentional), subsequent encounter
- T52.821SToxic effect of cycloparaffins, accidental (unintentional), sequela
- T52.822DToxic effect of cycloparaffins, intentional self-harm, subsequent encounter
- T52.822SToxic effect of cycloparaffins, intentional self-harm, sequela
- T52.823DToxic effect of cycloparaffins, assault, subsequent encounter
- T52.823SToxic effect of cycloparaffins, assault, sequela
- T52.824DToxic effect of cycloparaffins, undetermined, subsequent encounter
- T52.824SToxic effect of cycloparaffins, undetermined, sequela
- T52.891DToxic effect of other organic solvents, accidental (unintentional), subsequent encounter
- T52.891SToxic effect of other organic solvents, accidental (unintentional), sequela
- T52.892DToxic effect of other organic solvents, intentional self-harm, subsequent encounter
- T52.892SToxic effect of other organic solvents, intentional self-harm, sequela
- T52.893DToxic effect of other organic solvents, assault, subsequent encounter
- T52.893SToxic effect of other organic solvents, assault, sequela
- T52.894DToxic effect of other organic solvents, undetermined, subsequent encounter
- T52.894SToxic effect of other organic solvents, undetermined, sequela
- T59.821DToxic effect of hexamethylene diisocyanate, accidental (unintentional), subsequent encounter
- T59.821SToxic effect of hexamethylene diisocyanate, accidental (unintentional), sequela
- T59.822DToxic effect of hexamethylene diisocyanate, intentional self-harm, subsequent encounter
- T59.822SToxic effect of hexamethylene diisocyanate, intentional self-harm, sequela
- T59.823DToxic effect of hexamethylene diisocyanate, assault, subsequent encounter
- T59.823SToxic effect of hexamethylene diisocyanate, assault, sequela
- T59.824DToxic effect of hexamethylene diisocyanate, undetermined, subsequent encounter
- T59.824SToxic effect of hexamethylene diisocyanate, undetermined, sequela
- T65.851DToxic effect of medetomidine, accidental (unintentional), subsequent encounter
- T65.851SToxic effect of medetomidine, accidental (unintentional), sequela
- T65.852DToxic effect of medetomidine, intentional self-harm, subsequent encounter
- T65.852SToxic effect of medetomidine, intentional self-harm, sequela
- T65.853DToxic effect of medetomidine, assault, subsequent encounter
- T65.853SToxic effect of medetomidine, assault, sequela
- T65.854DToxic effect of medetomidine, undetermined, subsequent encounter
- T65.854SToxic effect of medetomidine, undetermined, sequela
- Z68.18Body mass index [BMI] 18.4 or less, adult
- Z68.19Body mass index [BMI] 18.5-19.9, adult
- Z77.013Contact with and (suspected) exposure to gadolinium
- Z77.32Contact with and (suspected) exposure to burn pits in war theater
- Z77.33Contact with and (suspected) exposure to Agent Orange
- Z77.40Contact with and (suspected) exposure to unspecified blast overpressure
- Z77.41Contact with and (suspected) exposure to low-level blast overpressure
- Z77.42Contact with and (suspected) exposure to high-level blast overpressure
- Z77.49Contact with and (suspected) exposure to other blast overpressure
- Z86.17Personal history of Clostridioides difficile infection
- Z87.8901Personal history of social gender transition
- Z87.8902Personal history of medical gender transition
- Z87.8903Personal history of surgical gender transition
- Z87.8904Personal history of intersex surgery
- Z87.8909Personal history of unspecified gender transition
- Z87.893Personal history of gender detransition
Removed from the exempt list (12)
- S23.420DSprain of sternoclavicular (joint) (ligament), subsequent encounter
- S23.420SSprain of sternoclavicular (joint) (ligament), sequela
- T52.8X1DToxic effect of other organic solvents, accidental (unintentional), subsequent encounter
- T52.8X1SToxic effect of other organic solvents, accidental (unintentional), sequela
- T52.8X2DToxic effect of other organic solvents, intentional self-harm, subsequent encounter
- T52.8X2SToxic effect of other organic solvents, intentional self-harm, sequela
- T52.8X3DToxic effect of other organic solvents, assault, subsequent encounter
- T52.8X3SToxic effect of other organic solvents, assault, sequela
- T52.8X4DToxic effect of other organic solvents, undetermined, subsequent encounter
- T52.8X4SToxic effect of other organic solvents, undetermined, sequela
- Z68.1Body mass index [BMI] 19.9 or less, adult
- Z87.890Personal history of sex reassignment
Revised codes (4)
The code stays the same and its title changed.
- L02.232Was: Carbuncle of back [any part, except buttock]
Now: Carbuncle of back [any part, except buttock and flank] - L03.312Was: Cellulitis of back [any part except buttock]
Now: Cellulitis of back [any part except buttock and flank] - L03.322Was: Acute lymphangitis of back [any part except buttock]
Now: Acute lymphangitis of back [any part except buttock and flank] - Z29.14Was: Encounter for prophylactic rabies immune globin
Now: Encounter for prophylactic rabies immune globulin
Deleted codes (30)
No longer valid for discharges and encounters on or after October 1, 2026. Check the Tabular List for the more specific codes that apply now.
- D69.1Qualitative platelet defects
- I42.0Dilated cardiomyopathy
- I42.8Other cardiomyopathies
- I49.8Other specified cardiac arrhythmias
- M72.2Plantar fascial fibromatosis
- M86.8X1Other osteomyelitis, shoulder
- M86.8X2Other osteomyelitis, upper arm
- M86.8X3Other osteomyelitis, forearm
- M86.8X4Other osteomyelitis, hand
- M86.8X5Other osteomyelitis, thigh
- M86.8X6Other osteomyelitis, lower leg
- M86.8X7Other osteomyelitis, ankle and foot
- M86.8X8Other osteomyelitis, other site
- S23.420ASprain of sternoclavicular (joint) (ligament), initial encounter
- S23.420DSprain of sternoclavicular (joint) (ligament), subsequent encounter
- S23.420SSprain of sternoclavicular (joint) (ligament), sequela
- T52.8X1AToxic effect of other organic solvents, accidental (unintentional), initial encounter
- T52.8X1DToxic effect of other organic solvents, accidental (unintentional), subsequent encounter
- T52.8X1SToxic effect of other organic solvents, accidental (unintentional), sequela
- T52.8X2AToxic effect of other organic solvents, intentional self-harm, initial encounter
- T52.8X2DToxic effect of other organic solvents, intentional self-harm, subsequent encounter
- T52.8X2SToxic effect of other organic solvents, intentional self-harm, sequela
- T52.8X3AToxic effect of other organic solvents, assault, initial encounter
- T52.8X3DToxic effect of other organic solvents, assault, subsequent encounter
- T52.8X3SToxic effect of other organic solvents, assault, sequela
- T52.8X4AToxic effect of other organic solvents, undetermined, initial encounter
- T52.8X4DToxic effect of other organic solvents, undetermined, subsequent encounter
- T52.8X4SToxic effect of other organic solvents, undetermined, sequela
- Z68.1Body mass index [BMI] 19.9 or less, adult
- Z87.890Personal history of sex reassignment
New codes (190)
Valid for discharges and encounters on or after October 1, 2026. Each code links to its page.
- C78.31Secondary malignant neoplasm of larynx
- C78.32Secondary malignant neoplasm of pharynx
- C79.83Secondary malignant neoplasm of oral cavity
- D69.11Glanzmann thrombasthenia
- D69.19Other qualitative platelet defects
- E89.830Post bariatric hypoglycemia
- E89.838Other postprocedural hypoglycemia
- F64.AGender identity disorder, in remission
- I42.00Dilated cardiomyopathy, unspecified
- I42.01Familial-genetic dilated cardiomyopathy
- I42.09Other dilated cardiomyopathy
- I42.81Arrhythmogenic cardiomyopathy
- I42.89Other cardiomyopathies not elsewhere classified
- I47.22Catecholaminergic polymorphic ventricular tachycardia [CPVT]
- I49.81Brugada syndrome
- I49.82Ventricular bigeminy
- I49.89Other specified cardiac arrhythmias not elsewhere classified
- J34.830Odontogenic sinusitis, maxillary sinus
- J34.831Odontogenic sinusitis, ethmoid sinus
- J34.832Odontogenic sinusitis, frontal sinus
- J34.833Odontogenic sinusitis, sphenoid sinus
- J34.839Odontogenic sinusitis, unspecified
- J4BPulmonary mycetoma
- K31.BHypertrophic pyloric stenosis, in childhood
- K6A.01Prevesical abscess
- K6A.09Other pelvic abscess
- K6A.8Other diseases of the pelvis, not elsewhere classified
- K74.0AHepatic fibrosis, moderate fibrosis
- K76.83Intestinal failure-associated liver disease
- L02.237Carbuncle of flank
- M04.3VEXAS syndrome
- M67.A01Plantar fasciitis, right foot
- M67.A02Plantar fasciitis, left foot
- M67.A09Plantar fasciitis, unspecified foot
- M72.20Plantar fascial fibromatosis, unspecified foot
- M72.21Plantar fascial fibromatosis, right foot
- M72.22Plantar fascial fibromatosis, left foot
- M86.8X11Other osteomyelitis, right shoulder
- M86.8X12Other osteomyelitis, left shoulder
- M86.8X19Other osteomyelitis, unspecified shoulder
- M86.8X21Other osteomyelitis, right upper arm
- M86.8X22Other osteomyelitis, left upper arm
- M86.8X29Other osteomyelitis, unspecified upper arm
- M86.8X31Other osteomyelitis, right forearm
- M86.8X32Other osteomyelitis, left forearm
- M86.8X39Other osteomyelitis, unspecified forearm
- M86.8X41Other osteomyelitis, right hand
- M86.8X42Other osteomyelitis, left hand
- M86.8X49Other osteomyelitis, unspecified hand
- M86.8X51Other osteomyelitis, right thigh
- M86.8X52Other osteomyelitis, left thigh
- M86.8X59Other osteomyelitis, unspecified thigh
- M86.8X61Other osteomyelitis, right lower leg
- M86.8X62Other osteomyelitis, left lower leg
- M86.8X69Other osteomyelitis, unspecified lower leg
- M86.8X71Other osteomyelitis, right ankle and foot
- M86.8X72Other osteomyelitis, left ankle and foot
- M86.8X79Other osteomyelitis, unspecified ankle and foot
- M86.8X80Other osteomyelitis, skull
- M86.8X81Other osteomyelitis, face and sinuses
- M86.8X89Other osteomyelitis, other site
- N99.860Intraoperative and postprocedural nipple ischemia
- N99.861Intraoperative and postprocedural nipple necrosis
- O00.121Right interstitial ectopic pregnancy without intrauterine pregnancy
- O00.122Left interstitial ectopic pregnancy without intrauterine pregnancy
- O00.129Unspecified interstitial ectopic pregnancy without intrauterine pregnancy
- O00.131Right interstitial ectopic pregnancy with intrauterine pregnancy
- O00.132Left interstitial ectopic pregnancy with intrauterine pregnancy
- O00.139Unspecified interstitial ectopic pregnancy with intrauterine pregnancy
- O00.31Cesarean scar ectopic pregnancy without intrauterine pregnancy
- O00.32Cesarean scar ectopic pregnancy with intrauterine pregnancy
- O00.41Cervical ectopic pregnancy without intrauterine pregnancy
- O00.42Cervical ectopic pregnancy with intrauterine pregnancy
- O00.511Right cornual ectopic pregnancy without intrauterine pregnancy
- O00.512Left cornual ectopic pregnancy without intrauterine pregnancy
- O00.519Unspecified cornual ectopic pregnancy without intrauterine pregnancy
- O00.521Right cornual ectopic pregnancy with intrauterine pregnancy
- O00.522Left cornual ectopic pregnancy with intrauterine pregnancy
- O00.529Unspecified cornual ectopic pregnancy with intrauterine pregnancy
- O31.40X0Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, not applicable or unspecified
- O31.40X1Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, fetus 1
- O31.40X2Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, fetus 2
- O31.40X3Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, fetus 3
- O31.40X4Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, fetus 4
- O31.40X5Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, fetus 5
- O31.40X9Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, other fetus
- O31.41X0Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, not applicable or unspecified
- O31.41X1Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, fetus 1
- O31.41X2Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, fetus 2
- O31.41X3Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, fetus 3
- O31.41X4Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, fetus 4
- O31.41X5Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, fetus 5
- O31.41X9Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, other fetus
- O31.42X0Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, not applicable or unspecified
- O31.42X1Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, fetus 1
- O31.42X2Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, fetus 2
- O31.42X3Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, fetus 3
- O31.42X4Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, fetus 4
- O31.42X5Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, fetus 5
- O31.42X9Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, other fetus
- O31.43X0Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, not applicable or unspecified
- O31.43X1Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, fetus 1
- O31.43X2Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, fetus 2
- O31.43X3Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, fetus 3
- O31.43X4Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, fetus 4
- O31.43X5Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, fetus 5
- O31.43X9Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, other fetus
- Q87.ALoeys-Dietz syndrome
- QA1.71Lynch syndrome
- QA1.790Familial cancer syndrome with pathogenic BRCA1 mutation
- QA1.791Familial cancer syndrome with pathogenic BRCA2 mutation
- QA1.792Li Fraumeni syndrome
- QA1.798Other inherited neoplasm predisposition syndrome of multiple systems
- R78.72Abnormal gadolinium level in blood
- T52.811AToxic effect of alkenes, accidental (unintentional), initial encounter
- T52.811DToxic effect of alkenes, accidental (unintentional), subsequent encounter
- T52.811SToxic effect of alkenes, accidental (unintentional), sequela
- T52.812AToxic effect of alkenes, intentional self-harm, initial encounter
- T52.812DToxic effect of alkenes, intentional self-harm, subsequent encounter
- T52.812SToxic effect of alkenes, intentional self-harm, sequela
- T52.813AToxic effect of alkenes, assault, initial encounter
- T52.813DToxic effect of alkenes, assault, subsequent encounter
- T52.813SToxic effect of alkenes, assault, sequela
- T52.814AToxic effect of alkenes, undetermined, initial encounter
- T52.814DToxic effect of alkenes, undetermined, subsequent encounter
- T52.814SToxic effect of alkenes, undetermined, sequela
- T52.821AToxic effect of cycloparaffins, accidental (unintentional), initial encounter
- T52.821DToxic effect of cycloparaffins, accidental (unintentional), subsequent encounter
- T52.821SToxic effect of cycloparaffins, accidental (unintentional), sequela
- T52.822AToxic effect of cycloparaffins, intentional self-harm, initial encounter
- T52.822DToxic effect of cycloparaffins, intentional self-harm, subsequent encounter
- T52.822SToxic effect of cycloparaffins, intentional self-harm, sequela
- T52.823AToxic effect of cycloparaffins, assault, initial encounter
- T52.823DToxic effect of cycloparaffins, assault, subsequent encounter
- T52.823SToxic effect of cycloparaffins, assault, sequela
- T52.824AToxic effect of cycloparaffins, undetermined, initial encounter
- T52.824DToxic effect of cycloparaffins, undetermined, subsequent encounter
- T52.824SToxic effect of cycloparaffins, undetermined, sequela
- T52.891AToxic effect of other organic solvents, accidental (unintentional), initial encounter
- T52.891DToxic effect of other organic solvents, accidental (unintentional), subsequent encounter
- T52.891SToxic effect of other organic solvents, accidental (unintentional), sequela
- T52.892AToxic effect of other organic solvents, intentional self-harm, initial encounter
- T52.892DToxic effect of other organic solvents, intentional self-harm, subsequent encounter
- T52.892SToxic effect of other organic solvents, intentional self-harm, sequela
- T52.893AToxic effect of other organic solvents, assault, initial encounter
- T52.893DToxic effect of other organic solvents, assault, subsequent encounter
- T52.893SToxic effect of other organic solvents, assault, sequela
- T52.894AToxic effect of other organic solvents, undetermined, initial encounter
- T52.894DToxic effect of other organic solvents, undetermined, subsequent encounter
- T52.894SToxic effect of other organic solvents, undetermined, sequela
- T59.821AToxic effect of hexamethylene diisocyanate, accidental (unintentional), initial encounter
- T59.821DToxic effect of hexamethylene diisocyanate, accidental (unintentional), subsequent encounter
- T59.821SToxic effect of hexamethylene diisocyanate, accidental (unintentional), sequela
- T59.822AToxic effect of hexamethylene diisocyanate, intentional self-harm, initial encounter
- T59.822DToxic effect of hexamethylene diisocyanate, intentional self-harm, subsequent encounter
- T59.822SToxic effect of hexamethylene diisocyanate, intentional self-harm, sequela
- T59.823AToxic effect of hexamethylene diisocyanate, assault, initial encounter
- T59.823DToxic effect of hexamethylene diisocyanate, assault, subsequent encounter
- T59.823SToxic effect of hexamethylene diisocyanate, assault, sequela
- T59.824AToxic effect of hexamethylene diisocyanate, undetermined, initial encounter
- T59.824DToxic effect of hexamethylene diisocyanate, undetermined, subsequent encounter
- T59.824SToxic effect of hexamethylene diisocyanate, undetermined, sequela
- T65.851AToxic effect of medetomidine, accidental (unintentional), initial encounter
- T65.851DToxic effect of medetomidine, accidental (unintentional), subsequent encounter
- T65.851SToxic effect of medetomidine, accidental (unintentional), sequela
- T65.852AToxic effect of medetomidine, intentional self-harm, initial encounter
- T65.852DToxic effect of medetomidine, intentional self-harm, subsequent encounter
- T65.852SToxic effect of medetomidine, intentional self-harm, sequela
- T65.853AToxic effect of medetomidine, assault, initial encounter
- T65.853DToxic effect of medetomidine, assault, subsequent encounter
- T65.853SToxic effect of medetomidine, assault, sequela
- T65.854AToxic effect of medetomidine, undetermined, initial encounter
- T65.854DToxic effect of medetomidine, undetermined, subsequent encounter
- T65.854SToxic effect of medetomidine, undetermined, sequela
- Z68.18Body mass index [BMI] 18.4 or less, adult
- Z68.19Body mass index [BMI] 18.5-19.9, adult
- Z77.013Contact with and (suspected) exposure to gadolinium
- Z77.32Contact with and (suspected) exposure to burn pits in war theater
- Z77.33Contact with and (suspected) exposure to Agent Orange
- Z77.40Contact with and (suspected) exposure to unspecified blast overpressure
- Z77.41Contact with and (suspected) exposure to low-level blast overpressure
- Z77.42Contact with and (suspected) exposure to high-level blast overpressure
- Z77.49Contact with and (suspected) exposure to other blast overpressure
- Z86.17Personal history of Clostridioides difficile infection
- Z87.8901Personal history of social gender transition
- Z87.8902Personal history of medical gender transition
- Z87.8903Personal history of surgical gender transition
- Z87.8904Personal history of intersex surgery
- Z87.8909Personal history of unspecified gender transition
- Z87.893Personal history of gender detransition
Source: CMS and NCHS FY2027 code addenda and POA exempt files. For the full detail, including changes to notes and the Alphabetic Index, see the official addenda on the CMS ICD-10 page.